Nektar Therapeutics

Pharmaceutical company · San Francisco, California, United States · Nasdaq: NKTR

Nektar Therapeutics is a pharmaceutical company headquartered in San Francisco, California, United States. Its shares trade on Nasdaq under the ticker NKTR. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Nektar Therapeutics at a glance

Typepharmaceutical company

HeadquartersSan Francisco, California, United States

Stock listingNasdaq: NKTR

SEC industryPharmaceutical Preparations

SEC CIK906709

What does Nektar Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $30 million sold (2024).

Frequently asked questions about Nektar Therapeutics

Where is Nektar Therapeutics headquartered?

Nektar Therapeutics is headquartered in San Francisco, California, United States.

What does Nektar Therapeutics do?

Nektar Therapeutics is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Nektar Therapeutics a public company?

Yes. Nektar Therapeutics trades on Nasdaq under the ticker NKTR.

Similar companies

Kyntra Bio, Inc.San Francisco, California, United States
Olema Pharmaceuticals, Inc.San Francisco, California, United States
GT Biopharma, Inc.San Francisco, California, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.